We have extended our capabilities for peptide drug discovery for antiviral-peptides using our innovative screening approach. Our case study for whole-Sars-CoV-2 virus has been published in ACS Pharmacology and Translational Science
shorturl.at/cLMQ0

Are you a PhD student or early post-doctoral researcher interested in engineering synthetic systems? Register your interest for the upcoming practical course 'Synthetic biology in action: engineering synthetic systems' by visiting: bit.ly/3SdB8pN
EMBO EMBL

Benim için ve araştırma grubumuz @sekerlab için bir gurur anı, doktora öğrencilerimizden Recep Erdem Ahan Recep Erdem Ahan sentetik biyoloji alanında evrensel düzeyde yaptığı çalışmalarla doktorasını tamamladı. Evrenselden kastım, makaleler yayınlamış olması değil (sayısını, niteliğini…

How can we implement genetic logic gates for mRNA therapeutics/vaccines for a better control, in our recent perspective paper 'Making the Next Generation of Therapeutics: mRNA Meets Synthetic Biology' in ACS Synthetic Bio we have discussed the opportunities
pubs.acs.org/doi/10.1021/ac…

Burcu Burcu Gündüz Ergün, PhD , a postdoctoral researcher has presented our recent work on developing an engineered probiotic yeast cell (S. boulardii) as a livint therapeutic for patients with anemia triggered by B12 deficiency at #FEMS2023 in Hamburg Germany- well done Burcu!

This is RNAGEN, a model to generate RNA sequences that are optimized for tasks such as targeting a protein. In collab. with SynBioLab, we show that the top sequences generated to target SOX2 selectively bind via in-vitro experiments. furkan ozden, Sina Barazandeh, Dogus Akboga, Urartu Şeker

Our collaborative work on UTR design using machine learning with Ercument Cicek Cicek Lab is out...we are developing mRNA therapeutics and new functional UTRs are critical for our ongoing efforts